Theriva Biologics, Inc. Operating Lease, Liability, Current
Theriva Biologics, Inc. (TOVX) had Operating Lease, Liability, Current of $525.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Notes › Leases
us-gaap:OperatingLeaseLiabilityCurrent · last filed 2026-08-11
- 2026-06-30: Operating Lease, Liability, Current $525.00K.
- 2026-03-31: Operating Lease, Liability, Current $510.00K.
- 2025-12-31: Operating Lease, Liability, Current $549.00K.
- 2025-09-30: Operating Lease, Liability, Current $618.00K.
| Period end | Operating Lease, Liability, Current |
|---|---|
| 2026-06-30 | $525.00K 10-Q · filed 2026-08-11 |
| 2026-03-31 | $510.00K 10-Q · filed 2026-05-05 |
| 2025-12-31 | $549.00K 10-Q · filed 2026-08-11 |
| 2025-09-30 | $618.00K 10-Q · filed 2025-11-12 |
| 2025-06-30 | $612.00K 10-Q · filed 2025-08-11 |
| 2025-03-31 | $568.00K 10-Q · filed 2025-05-14 |
| 2024-12-31 | $539.00K 10-K · filed 2026-03-12 |
| 2024-09-30 | $541.00K 10-Q · filed 2024-11-12 |
| 2024-06-30 | $513.00K 10-Q · filed 2024-08-13 |
| 2024-03-31 | $498.00K 10-Q · filed 2024-05-07 |
| 2023-12-31 | $487.00K 10-K · filed 2025-03-06 |
| 2023-09-30 | $461.00K 10-Q · filed 2023-11-13 |
| 2023-06-30 | $452.00K 10-Q · filed 2023-08-08 |
| 2023-03-31 | $437.00K 10-Q · filed 2023-05-11 |
| 2022-12-31 | $216.00K 10-K · filed 2024-03-25 |
| 2022-09-30 | $157.00K 10-K · filed 2023-03-30 |
| 2022-06-30 | $128.00K 10-K · filed 2023-03-30 |
| 2022-03-31 | $126.00K 10-Q · filed 2022-05-16 |
| 2021-12-31 | $124.00K 10-K · filed 2023-03-30 |
| 2021-09-30 | $175.00K 10-Q · filed 2021-11-03 |
| 2021-06-30 | $196.00K 10-Q · filed 2021-08-05 |
| 2021-03-31 | $297.00K 10-Q · filed 2021-05-05 |
| 2020-12-31 | $287.00K 10-K · filed 2022-03-16 |
| 2020-09-30 | $278.00K 10-Q · filed 2020-11-10 |
| 2020-06-30 | $268.00K 10-Q · filed 2020-08-06 |
| 2020-03-31 | $258.00K 10-Q · filed 2020-05-05 |
| 2019-12-31 | $249.00K 10-K · filed 2021-03-04 |
| 2019-09-30 | $241.00K 10-Q · filed 2019-11-04 |
| 2019-06-30 | $233.00K 10-Q · filed 2019-08-08 |
| 2019-03-31 | $225.00K 10-Q · filed 2019-05-08 |
| 2019-01-01 | $939.00K 10-K · filed 2020-02-20 |
| 2018-12-31 | $0.00 10-K · filed 2020-02-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |